abrdn Life Sciences Inve... News - HQL

Company Name	Stock Ticker Symbol	Market	Type
abrdn Life Sciences Investors	HQL	NYSE	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.055	-0.42%	12.92	11:40:44

Open Price	Low Price	High Price	Close Price	Prev Close
12.96	12.8993	12.97		12.975

more quote information »

Recent News

Date	Time	Source	Heading
4/16/2024	8:52	IHNW	FeaturedCannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix
2/29/2024	12:37	EDGAR2	Form NPORT-P - Monthly Portfolio Investments Report on Form..
2/07/2024	07:55	EDGAR2	Form SC 13D/A - General statement of acquisition of..
1/12/2024	11:41	EDGAR2	Form SC 13D/A - General statement of acquisition of..
1/04/2024	14:23	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/02/2024	16:34	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/29/2023	07:54	EDGAR2	Form SC 13D - General statement of acquisition of beneficial..
12/22/2023	14:15	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
12/22/2023	14:12	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
12/12/2023	10:57	EDGAR2	Form N-CEN - Annual Report for Registered Investment..
12/11/2023	16:11	EDGAR2	Form N-CSR - Certified Shareholder Report
11/15/2023	15:13	EDGAR2	Form NPORT-P - Monthly Portfolio Investments Report on Form..
11/06/2023	15:39	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
11/06/2023	15:39	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
11/06/2023	15:37	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
11/06/2023	15:36	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
11/06/2023	15:36	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
11/06/2023	15:35	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
11/06/2023	15:34	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
11/06/2023	15:33	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
11/06/2023	15:33	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
11/06/2023	15:32	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
11/06/2023	15:31	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
11/06/2023	15:30	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
11/06/2023	15:30	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
11/06/2023	15:29	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
10/27/2023	16:57	BW	Tekla Funds Approve New Investment Advisory Agreements With..
10/13/2023	18:26	BW	Tekla Funds Implore Shareholders of THQ and THW to Vote..
10/05/2023	14:05	BW	Tekla Funds Urge Shareholders to Vote Immediately to..
9/29/2023	10:35	BW	Tekla Life Sciences Investors Paid Distribution
9/27/2023	09:33	EDGAR2	Form POS EX - Post-effective amendment adding exhibits to..
9/25/2023	17:35	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/20/2023	18:40	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/13/2023	08:51	BW	Tekla Funds Announce Adjournment of Special Meetings and..
9/12/2023	17:06	EDGAR2	Form 8-K - Current report
8/30/2023	14:39	BW	Tekla Funds Announce Second Adjournment of Special Meetings..
8/28/2023	15:31	EDGAR2	Form NPORT-P - Monthly Portfolio Investments Report on Form..
8/25/2023	14:35	EDGAR2	Form N-CSR/A - Certified Shareholder Report: [Amend]
8/22/2023	15:35	EDGAR2	Form N-CSR/A - Certified Shareholder Report: [Amend]
8/15/2023	09:55	BW	Tekla Life Sciences Investors Declares Distribution
8/14/2023	15:10	BW	Tekla Funds Announce Adjournment of Special Meetings
8/04/2023	12:05	EDGAR2	Form N-PX - Annual Report of proxy voting record of..
6/30/2023	10:35	BW	Tekla Life Sciences Investors Paid Distribution
6/20/2023	17:48	BW	Tekla Capital Management LLC Announces Proposed Transaction
5/15/2023	10:36	BW	Tekla Life Sciences Investors Declares Distribution